$BLSM

$26.82▲ -0.1% YTD

4 SEC 13D/G filings tracked · Last updated Sep 18, 2026

Filing History

News

BLSM ▼ -0.1% - BlossomHill Therapeutics, Inc.

CP $26.82▲ -0.1%Sep 18, 2026 · ThinkSabio Blog

$BLSM - BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results…

News

BLSM ▲ +6.9% - BlossomHill Therapeutics, Inc.

CP $23.19▲ +6.9%Sep 15, 2026 · ThinkSabio Blog

$BLSM - BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™…

News

BLSM ▲ +0.5% - BlossomHill Therapeutics, Inc.

CP $19.38▲ +0.5%Sep 3, 2026 · ThinkSabio Blog

$BLSM - BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Con…

News

BLSM ▼ -2.7% - BlossomHill Therapeutics, Inc.

CP $18.30▲ -2.7%Sep 1, 2026 · ThinkSabio Blog

$BLSM - BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGF…